You can read some of the March 18 print issue of Chain Drug Review here. In CDR’s digital editions, you can find special sections and additional pages not posted online. You will need to register, but subscription is free!
Direct and indirect remuneration was initiated with best intentions. DIR was originally introduced to create a pharmacy reimbursement model wherein payers would reimburse pharmacies based on patient outcomes, a pay-for-performance model. It included adherence measures and the use of generic drugs so that pharmacies would focus on better outcomes and lower costs — otherwise known
BONITA SPRINGS, Fla. — The emerging leaders of the Emerson Group are bringing their digital commerce expertise to retailers. The team was selected by founder and president Scott Emerson, and the members have honed their e-commerce skills with CPG brands. Now they want to enable retailers — like the ones they spoke to at the
GREAT NECK, N.Y. — With more consumers turning to retail pharmacies as a resource for their health care needs, First Quality continues to invest in its clinical support services to provide education and support on incontinence, menstrual care and baby care. The clinical support reflects First Quality’s heritage in the health care industry, which began
SKILLMAN, N.J. — Last fall, Kenvue Inc., the world’s largest pure-play consumer health company by revenue, announced a major extension to its Listerine line with Listerine Clinical Solutions. The new lineup includes: Listerine Clinical Solutions Antiseptic Gum Health Mouthwash, Clinical Solutions Breath Defense Mouthwash and Clinical Solutions Teeth Strength – Mouthwash. “As the No. 1
At the beginning of the month, retail pharmacy advocates were engaged in a full-court press to convince members of Congress, who were locked in a protracted battle over federal spending and a possible government shutdown, to include meaningful PBM reform in a final budget deal. A coalition of industry groups urged lawmakers to enact what
Stew Turley passed away last month, a victim of deteriorating health and advancing age. To those who knew and worked with Turley, no explanation of the man’s impact and influence on chain drug retailing in America during the last half of the 20th century would suffice to explain the impact the news of his passing
